The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Parkinson's disease: a dual‐hit hypothesis
Open accessAbstract
Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal period during which several non-motor features develop, in particular, impairment of olfaction, vagal dysfunction and sleep disorder. Early sites of Lewy pathology are the olfactory bulb and enteric plexus of the stomach. We propose that a neurotropic pathogen, probably viral, enters the brain via two routes: (i) nasal, with anterograde progression into the temporal lobe; and (ii) gastric, secondary to swallowing of nasal secretions in saliva. These secretions might contain a neurotropic pathogen that, after penetration of the epithelial lining, could enter axons of the Meissner's plexus and, via transsynaptic transmission, reach the preganglionic parasympathetic motor neurones of the vagus nerve. This would allow retrograde transport into the medulla and, from here, into the pons and midbrain until the substantia nigra is reached and typical aspects of disease commence. Evidence for this theory from the perspective of olfactory and autonomic dysfunction is reviewed, and the possible routes of pathogenic invasion are considered. It is concluded that the most parsimonious explanation for the initial events of sporadic Parkinson's disease is pathogenic access to the brain through the stomach and nose - hence the term 'dual-hit'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The double-hit hypothesis proposed by Hawkes et al.135 supports their theory, pointing out that a-synuclein pathology is transmitted to the midbrain through two different routes, namely, from the nasal cavity to the temporal lobe or from the stomach, followed by nasal secretions in swallowed saliva.135”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [135]
Experimental — accuracy not yet measuredIn the citing paper
“Conversely, when the α-synuclein pathology firstly occurred in the olfactory bulbs, it spread further to the brain via the olfactory tract but it also went down to the ENS and it damaged its neurons [402].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [402]
In the citing paper
“Braak and colleagues hypothesized that alpha-synuclein pathology might start in either the OB and/or in the ENS possibly by an unknown pathogen and/or environmental toxin and then progresses towards the SN and further areas in the CNS.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Hawkes et al., 2007
In the citing paper
“The vagal nerve might provide a path for the spread of alpha-synuclein pathology from the ENS to the brain through the brainstem, midbrain, basal forebrain and finally the cortical areas (Braak et al., 2003;Hawkes et al., 2007)”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Hawkes et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Self-citationHummel, T., Sekinger, B., Wolf, S. R., Pauli, E., & Kobal, G. (1997) · Chemical Senses · doi:10.1093/chemse/22.1.39 · Cited by 2,501
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Self-citationPaxinos, G., & Jürgen, K. (2004) · Cited by 1,478
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Self-citationSchenck, C. H., Bundlie, S. R., & Mahowald, M. W. (1996) · Neurology · doi:10.1212/wnl.46.2.388 · Cited by 1,083
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
Litvan, I., Bhatia, K. P., Burn, D. J., Goetz, C. G., Lang, A. E., McKeith, I. G., Quinn, N. P., Sethi, K. D., Shults, C. W., & Wenning, G. K. (2003) · Movement Disorders · doi:10.1002/mds.10459 · Cited by 1,011
Research works printed but not linked: 4
- Braak H, 2005, Parkinson's Disease: Progress in Research., 1
- Sulla M, 1996, Gastric emptying time and gastric motility in patients with untreated Parkinson's disease, Mov Disord, 11, 1041
- Schenck CH, 2003, REM behavior disorder (RBD), delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maximum tonic and/or phasic electromyographic abnormalities found during REM sleep, Sleep, 26, 316
- 10.1042/bse0410139 · DOI
Cited by
Sorted by citations
Items 201–300 of 1,000
Tanei, Z., Saito, Y., Ito, S., Matsubara, T., Motoda, A., Yamazaki, M., Sakashita, Y., Kawakami, I., Ikemura, M., Tanaka, S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02233-8 · Cited by 88
Changes in Olfactory Bulb Volume in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Li, J., Cheng-zhi, G., Su, J., Zhu, L., Zhou, Y., Huang, H.-Y., & Liu, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149286 · Cited by 81
Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease
Cantu-Jungles, T. M., Rasmussen, H. E., & Hamaker, B. R. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00663 · Cited by 86
Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson’s Disease?
Barnum, C. J., & Tansey, M. G. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0283-6 · Cited by 82
Blandini, F., Balestra, B., Levandis, G., Cervio, M., Greco, R., Tassorelli, C., Colucci, M., Faniglione, M., Bazzini, E., Nappi, G., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.035 · Cited by 81
123I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies
Orimo, S., Yogo, M., Nakamura, T., Suzuki, M., & Watanabe, H. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.001 · Cited by 83
Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?
Salat-Foix, D., Tran, K., Ranawaya, R., Meddings, J., & Suchowersky, O. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013202 · Cited by 80
Selective neuronal vulnerability in Parkinson's disease
González‐Rodríguez, P., Zampese, E., & Surmeier, D. J. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.02.005 · Cited by 80
Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer’s disease
Saiz-Sanchez, D., De la Rosa-Prieto, C., Ubeda-Banon, I., & Martinez-Marcos, A. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0771-3 · Cited by 79
Relationship Between Obesity, Alzheimer’s Disease, and Parkinson’s Disease: an Astrocentric View
Martín-Jiménez, C., Gaitán-Vaca, D. M., Echeverría, V., González, J., & Barreto, G. E. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0193-8 · Cited by 80
Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 91
Boros, F. A., Maszlag-Török, R., Vécsei, L., & Klivènyi, P. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146672 · Cited by 77
Zhu, H. C., Zhao, J., Luo, C. Y., & Li, Q. Q. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9560-0 · Cited by 78
Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders
Saito, Y., Shioya, A., Sano, T., Sumikura, H., Murata, M., & Murayama, S. (2016) · Movement Disorders · doi:10.1002/mds.26463 · Cited by 76
Ghrelin and Neurodegenerative Disorders—a Review
Shi, L.-M., Du, X.-X., Jiang, H., & Xie, J.-X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9729-1 · Cited by 73
Transmission of α-synucleinopathy from olfactory structures deep into the temporal lobe
Mason, D. M., Nouraei, N., Pant, D. B., Miner, K. M., Hutchison, D. F., Luk, K. C., Stolz, J. F., & Leak, R. K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0113-4 · Cited by 75
Animal models of brain-first and body-first Parkinson's disease
Berge, N. V. D., & Ulusoy, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105599 · Cited by 80
Sumikura, H., Takao, M., Hatsuta, H., Ito, S., Nakano, Y., Uchino, A., Nogami, A., Saito, Y., Mochizuki, H., & Murayama, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0236-9 · Cited by 74
Svensson, E., Horváth–Puhó, E., Stokholm, M. G., Sørensen, H. T., Henderson, V. W., & Borghammer, P. (2016) · Movement Disorders · doi:10.1002/mds.26761 · Cited by 75
Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease
Kuštrimović, N. Z., Marino, F., & Cosentino, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181009161048 · Cited by 74
Review: The future of cell therapies and brain repair: P arkinson's disease leads the way
Petit, G. H., Olsson, T. T., & Brundin, P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12110 · Cited by 74
Chen, S., & Lin, C. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00839-6 · Cited by 85
Olfactory system pathology as a model of Lewy neurodegenerative disease
Duda, J. E. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.042 · Cited by 74
How strong is the evidence that Parkinson's disease is a prion disorder?
Brundin, P., Ma, J., & Kordower, J. H. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000349 · Cited by 76
Kon, T., Tomiyama, M., & Wakabayashi, K. (2019) · Neuropathology · doi:10.1111/neup.12597 · Cited by 77
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 75
Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei
Emmi, A., Rizzo, S., Barzon, L., Sandre, M., Carturan, E., Sinigaglia, A., Riccetti, S., Barbera, M. D., Rafael Boscolo-berto, A., Cocco, P., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00467-3 · Cited by 75
Olfactory pathogenesis of idiopathic Parkinson disease revisited
Lerner, A., & Bagic, A. I. (2008) · Movement Disorders · doi:10.1002/mds.22066 · Cited by 73
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease
Lee, J. M., Derkinderen, P., Kordower, J. H., Freeman, R. L., Muñoz, D. G., Kremer, T., Zago, W. M., Hutten, S. J., Adler, C. H., Serrano, G. E., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw103 · Cited by 72
Beach, T. G., Adler, C. H., Sue, L. I., Shill, H. A., Driver‐Dunckley, E. D., Mehta, S. H., Intorcia, A. J., Glass, M. J., Walker, J. E., Arce, R. A., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212733 · Cited by 79
Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases
Walker, L. C., & LeVine, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.399378 · Cited by 75
Willison, L. D., Kudo, T., Loh, D. H., Kuljis, D. A., & Colwell, C. S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.014 · Cited by 73
Soraci, L., Gambuzza, M. E., Biscetti, L., Laganà, P., Russo, C. L., Buda, A., Barresi, G., Corsonello, A., Lattanzio, F., Lorello, G., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11491-3 · Cited by 76
Lees, A. J. (2009) · Neurology · doi:10.1212/wnl.0b013e318198daec · Cited by 71
Environment-contact administration of rotenone: A new rodent model of Parkinson’s disease
Liu, Y., Sun, J., Song, L.-K., Li, J., Chu, S., Yuan, Y., & Chen, N. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.058 · Cited by 69
Beach, T. G., Adler, C. H., Serrano, G. E., Sue, L. I., Walker, D. G., Dugger, B. N., Shill, H. A., Driver‐Dunckley, E. D., Caviness, J. N., Intorcia, A. J., et al. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-150680 · Cited by 70
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
Chen, S., Tan, H., Wu, Z., Sun, C., He, J.-X., Li, X., & Shao, M. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.11.024 · Cited by 69
Úbeda‐Bañón, I., Saiz‐Sánchez, D., de la Rosa‐Prieto, C., & Martı́nez-Marcos, A. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0651-2 · Cited by 71
The pathomechanisms underlying Parkinson's disease
Jellinger, K. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.877842 · Cited by 74
For the assessment of intestinal permeability, size matters.
Vojdani, A. (2013) · PubMed · Cited by 69
Early constipation predicts faster dementia onset in Parkinson’s disease
Camacho, M., Macleod, A. D., Maple‐Grødem, J., Evans, J., Breen, D. P., Cummins, G. A., Wijeyekoon, R., Greenland, J. C., Alves, G. W., Tysnes, O., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00191-w · Cited by 71
Riederer, P. F., Nagatsu, T., Youdim, M. B. H., Wulf, M., Dijkstra, J. M., & Sian‐Hülsmann, J. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02630-9 · Cited by 71
View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication
Reichmann, H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.016 · Cited by 68
Controversies over the staging of α-synuclein pathology in Parkinson’s disease
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0381-3 · Cited by 68
Schaser, A. J., Stackhouse, T. L., Weston, L. J., Kerstein, P. C., Osterberg, V. R., López, C. S., Dickson, D. W., Luk, K. C., Meshul, C. K., Woltjer, R. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01026-0 · Cited by 63
Parkinsonism as a Third Wave of the COVID-19 Pandemic?
Beauchamp, L. C., Finkelstein, D. I., Bush, A. I., Evans, A. H., & Barnham, K. J. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202211 · Cited by 68
Bargar, C., Luca, C. M. G. D., Devigili, G., Elia, A. E., Cilia, R., Portaleone, S. M., Wang, W., Tramacere, I., Bistaffa, E., Cazzaniga, F. A., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00491-y · Cited by 67
Andersen, K. B., Krishnamurthy, A., Just, M. K., Berge, N. V. D., Skjærbæk, C., Horsager, J., Knudsen, K., Vogel, J. W., Toledo, J. B., Attems, J., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01910-9 · Cited by 74
Rey, N. L., George, S., & Brundin, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12299 · Cited by 67
Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat
Phillips, R. J., Walter, G. C., Ringer, B. E., Higgs, K. M., & Powley, T. L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.025 · Cited by 66
Shin, E., Rogers, J. T., Devoto, P., Björklund, A., & Carta, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.011 · Cited by 66
Hypothesis: A role for EBV-induced molecular mimicry in Parkinson's disease
Woulfe, J., Gray, M. T., Gray, D. A., Muñoz, D. G., & Middeldorp, J. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.031 · Cited by 67
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
Yemula, N., Dietrich, C. M., Dostal, V., & Hornberger, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212707 · Cited by 71
Can cellular models revolutionize drug discovery in Parkinson's disease?
Schüle, B., Pera, R. A. R., & Langston, J. W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.014 · Cited by 64
Dunning, C. J. R., George, S., & Brundin, P. (2013) · Prion · doi:10.4161/pri.23806 · Cited by 66
Alam, S. B., Willows, S. D., Kulka, M., & Sandhu, J. K. (2020) · European Journal of Neurology · doi:10.1111/ene.14442 · Cited by 61
Giuffrè, M., Moretti, R., Campisciano, G., da Silveira, A. B. M., Monda, V., Comar, M., Bella, S. D., Antonello, R. M., Luzzati, R., & Crocè, L. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113705 · Cited by 64
The role of immunity in Huntington's disease
Soulet, D., & Cicchetti, F. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.28 · Cited by 62
Majbour, N. K., Aasly, J. O., Hustad, E., Thomas, M. A., Vaikath, N. N., Elkum, N. B., van de Berg, W. D. J., Tokuda, T., Mollenhauer, B., Berendse, H. W., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00192-4 · Cited by 62
Functional Amyloids Are the Rule Rather Than the Exception in Cellular Biology
Balistreri, A., Goetzler, E., & Chapman, M. R. (2020) · Microorganisms · doi:10.3390/microorganisms8121951 · Cited by 64
Parkinsonism in viral, paraneoplastic, and autoimmune diseases
Xing, F., Marsili, L., & Truong, D. D. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120014 · Cited by 62
Reyes, J. F., Ekmark-Léwen, S., Perdiki, M., Klingstedt, T., Hoffmann, A., Wiechec, E., Nilsson, P., Nilsson, K. P. R., Alafuzoff, I., Ingelsson, M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01136-3 · Cited by 59
G ut F eelings Ab out α‐ S ynuclein in G astrointestinal B iopsies: B iomarker in the M aking?
Ruffmann, C., & Parkkinen, L. (2016) · Movement Disorders · doi:10.1002/mds.26480 · Cited by 60
Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria
Esteves, A. R., Muñoz, M., Nunes‐Costa, D., Candeias, E., Silva, D. F., Magalhães, J. D., Pereira-Santos, A. R., Ferreira, I. L., Alarico, S., Tiago, I., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-326023 · Cited by 61
Dzamko, N. L. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_7 · Cited by 62
Morais, L. H., Hara, D. B., Bicca, M. A., Poli, A., & Takahashi, R. N. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000389 · Cited by 58
Gut microbiota in dementia with Lewy bodies
Nishiwaki, H., Ueyama, J., Kashihara, K., Ito, M., Hamaguchi, T., Maeda, T., Tsuboi, Y., Katsuno, M., Hirayama, M., & Ohno, K. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00428-2 · Cited by 59
“Smelling and Tasting” Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease
Oppo, V., Melis, M., Melis, M., Barbarossa, I. T., & Cossu, G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00043 · Cited by 61
Defining Parkinson’s Disease: Past and Future
Kulcsárová, K., Škorvánek, M., Postuma, R. B., & Berg, D. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230411 · Cited by 73
Labrie, V., & Brundin, P. (2017) · Journal of Innate Immunity · doi:10.1159/000479653 · Cited by 60
Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
Koziorowski, D., Figura, M., Milanowski, Ł., Szlufik, S., Alster, P., Madetko‐Alster, N., & Friedman, A. (2021) · Cells · doi:10.3390/cells10030656 · Cited by 59
Uchihara, T. (2016) · Neuropathology · doi:10.1111/neup.12348 · Cited by 55
The Role of Epigenetics in Neuroinflammatory-Driven Diseases
Giallongo, S., Longhitano, L., Denaro, S., D’Aprile, S., Torrisi, F., Spina, E. L., Giallongo, C., Mannino, G., Furno, D. L., Zappalà, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315218 · Cited by 62
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Carceles‐Cordon, M., Weintraub, D., & Chen‐Plotkin, A. S. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.021 · Cited by 63
Fornai, M., Pellegrini, C., Antonioli, L., Segnani, C., Ippolito, C., Barocelli, E., Ballabeni, V., Vegezzi, G., Harraq, Z. A., Blandini, F., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228510 · Cited by 56
Appendectomy may delay P arkinson's disease Onset
Mendes, A., Gonçalves, A., Vila‐Chã, N., Moreira, I. C., Fernandes, J., Damásio, J., Teixeira-Pinto, A. M., Taipa, R. J. F., Lima, A. B., & Cavaco, S. (2015) · Movement Disorders · doi:10.1002/mds.26311 · Cited by 60
Constipation and risk of Parkinson’s disease: A Danish population-based cohort study
Svensson, E., Henderson, V. W., Borghammer, P., Horváth–Puhó, E., & Sørensen, H. T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.016 · Cited by 57
The Gut and Nonmotor Symptoms in Parkinson's Disease
Klingelhoefer, L., & Reichmann, H. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.027 · Cited by 53
Naudet, N., Antier, E., Gaillard, D., Morignat, E., Lakhdar, L., Baron, T., & Bencsik, A. A. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx092 · Cited by 53
Sharma, S., Awasthi, A., & Singh, S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134516 · Cited by 55
Dou, T., Zhou, L., & Kurouski, D. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c00820 · Cited by 54
The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s Disease
Visanji, N. P., Mollenhauer, B., Beach, T. G., Adler, C. H., Coffey, C. S., Kopil, C., Dave, K. D., Foroud, T., Chahine, L. M., Jennings, D. L., et al. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0366 · Cited by 54
Gastrointestinal Transit Time in Parkinson’s Disease Using a Magnetic Tracking System
Knudsen, K., Haase, A., Fedorova, T. D., Bekker, A. C., Østergaard, K., Krogh, K., & Borghammer, P. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171131 · Cited by 53
A 5-Year Follow-up Study on the Relationship between Obstructive Sleep Apnea and Parkinson Disease
Sheu, J., Lee, H., Lin, H., Kao, L., & Chung, S. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5274 · Cited by 53
Fritsch, T., Smyth, K. A., Wallendal, M. S., Hyde, T., Leo, G. J., & Geldmacher, D. (2012) · Southern Medical Journal · doi:10.1097/smj.0b013e318273a60d · Cited by 52
Calderón‐Garcidueñas, L., Reynoso-Robles, R., Pérez-Guillé, B., Mukherjee, P. S., & González-Maciel, A. (2017) · Environmental Research · doi:10.1016/j.envres.2017.08.008 · Cited by 51
van Kessel, S. P., & Aidy, S. E. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01087 · Cited by 55
Dugger, B. N., Hidalgo, J. A., Chiarolanza, G., Mariner, M., Henry-Watson, J., Sue, L. I., & Beach, T. G. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121864 · Cited by 53
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Perez‐Pardo, P., Hartog, M., Garssen, J., & Kraneveld, A. D. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0129-2 · Cited by 53
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder
Kolicheski, A., Turcano, P., Tamvaka, N., McLean, P. J., Springer, W., Savica, R., & Ross, O. A. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223380 · Cited by 58
Neuropathology in transplants in Parkinson's disease
Brundin, P., & Kordower, J. H. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59575-1.00010-7 · Cited by 55
Alavi, M., Dostrovsky, J. O., Hodaie, M., Lozano, A. M., & Hutchison, W. D. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.021 · Cited by 51
Electrophysiological Evaluation of Oropharyngeal Dysphagia in Parkinson’s Disease
Erteki̇n, C. (2014) · Journal of Movement Disorders · doi:10.14802/jmd.14008 · Cited by 52
Cell Transplantation and Gene Therapy in Parkinson's Disease
Wakeman, D. R., Dodiya, H. B., & Kordower, J. H. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20233 · Cited by 52
Vacchi, E., Kaelin‐Lang, A., & Melli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145030 · Cited by 51
Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Hirayama, M., Nishiwaki, H., Hamaguchi, T., & Ohno, K. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00511-2 · Cited by 51
Montanari, M., Imbriani, P., Bonsi, P., Martella, G., & Peppe, A. (2023) · Biomedicines · doi:10.3390/biomedicines11061560 · Cited by 51
Cersosimo, M. G. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2733-6 · Cited by 49
Sniffing out pharmacology: interactions of drugs with human olfaction
Lötsch, J., Geißlinger, G., & Hummel, T. R. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.004 · Cited by 50
Metadata
- Authors
- Hawkes, C. H., Del Tredici, K., & Braak, H.
- Affiliations
- Queen's Hospital (GB)
- Goethe University Frankfurt (DE)
- Corresponding author
- Hawkes, C. H.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2007-10-24
- Volume
- 33
- Issue
- 6
- Pages
- 599-614
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- PMC
- PMC7194308
- OpenAlex
- W2105047187
- Cited by
- 1,021
- References
- 163
- Citations by year
- 2026: 35 · 2025: 59 · 2024: 87 · 2023: 82 · 2022: 104 · 2021: 117 · 2020: 83 · 2019: 59 · 2018: 49 · 2017: 63 · 2016: 41 · 2015: 33 · 2014: 32 · 2013: 40 · 2012: 33
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, neurotropic viruses, olfactory dysfunction, Lewy bodies, vagal dysfunction, sleep disorder, olfactory bulb, submucosal plexus, vagus nerve, substantia nigra, prodromal Parkinson's disease, viral pathogenesis
- MeSH terms
- Animals, Olfaction Disorders, Gastrointestinal Diseases, Heart Diseases, Humans, Models, Neurological, Parkinson Disease, Sleep Wake Disorders, Virus Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
